Cargando…

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation

BACKGROUND: Polypharmacy is highly prevalent in elderly people with chronic conditions, including atrial fibrillation (AF). The impact of polypharmacy on adverse outcomes and on treatment effectiveness in elderly patients with AF remains unaddressed. METHODS AND RESULTS: We studied 338 810 AF patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Nemin, Alam, Aniqa B., Lutsey, Pamela L., MacLehose, Richard F., Claxton, J'Neka S., Chen, Lin Y., Chamberlain, Alanna M., Alonso, Alvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429010/ https://www.ncbi.nlm.nih.gov/pubmed/32448024 http://dx.doi.org/10.1161/JAHA.119.015089

Ejemplares similares

Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database
por: Subramanya, Vinita, et al.
Publicado: (2021)

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2018)

Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation
por: O’Neal, Wesley T., et al.
Publicado: (2019)

Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants
por: Shao, Iris Yuefan, et al.
Publicado: (2021)

A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants
por: Claxton, J’Neka S., et al.
Publicado: (2018)

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
por: O'Neal, Wesley T., et al.
Publicado: (2018)

Association of household income and adverse outcomes in patients with atrial fibrillation
por: LaRosa, Anna Rose, et al.
Publicado: (2020)

Association of arterial stiffness with incident atrial fibrillation: a cohort study
por: Almuwaqqat, Zakaria, et al.
Publicado: (2021)

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
por: Norby, Faye L., et al.
Publicado: (2017)

Association and impact of hypertension defined using the 2017 AHA/ACC guidelines on the risk of atrial fibrillation in The Atherosclerosis Risk in Communities study
por: Rattani, Anas, et al.
Publicado: (2019)

Use of SGLT2i and ARNi in patients with atrial fibrillation and heart failure in 2021–2022: an analysis of real-world data
por: Alonso, Alvaro, et al.
Publicado: (2023)

Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
por: Li, Linzi, et al.
Publicado: (2023)

Impact of Atrial Fibrillation on Healthcare Utilization in the Community: The Atherosclerosis Risk in Communities Study
por: Bengtson, Lindsay G. S., et al.
Publicado: (2014)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
por: Zakai, Neil A., et al.
Publicado: (2021)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
por: MacLehose, Richard F., et al.
Publicado: (2021)

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
por: Lutsey, Pamela L., et al.
Publicado: (2019)

Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
por: Alonso, Alvaro, et al.
Publicado: (2021)

Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018
por: Lutsey, Pamela L., et al.
Publicado: (2021)

Associations of Atrial Fibrillation with Mild Cognitive Impairment and Dementia: An Investigation Using SPRINT Research Materials
por: Alam, Aniqa B., et al.
Publicado: (2022)

Identification of Incident Atrial Fibrillation From Electronic Medical Records
por: Chamberlain, Alanna M., et al.
Publicado: (2022)

Association of Atrial Fibrillation With Incidence of Extracranial Systemic Embolic Events: The ARIC Study
por: Shi, Mengyuan, et al.
Publicado: (2020)

Low Serum Magnesium is Associated with Incident Dementia in the ARIC-NCS Cohort
por: Alam, Aniqa B., et al.
Publicado: (2020)

Associations of Serum Magnesium with Brain Morphology and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities-Neurocognitive Study
por: Alam, Aniqa B., et al.
Publicado: (2021)

Endogenous Carbamylation of Renal Medullary Proteins
por: Claxton, J'Neka S., et al.
Publicado: (2013)

Systems-level analysis reveals selective regulation of Aqp2 gene expression by vasopressin
por: Sandoval, Pablo C., et al.
Publicado: (2016)

Autoimmune disease and risk of postpartum venous thromboembolism
por: Walker, Rob F., et al.
Publicado: (2023)

Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer’s Disease: The Atherosclerosis Risk in Communities Study (ARIC)
por: Lutsey, Pamela L., et al.
Publicado: (2016)

Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort.
por: French, Simone A., et al.
Publicado: (2020)

Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
por: Almuwaqqat, Zakaria, et al.
Publicado: (2019)

Association of physical activity with the incidence of atrial fibrillation in persons > 65 years old: the Atherosclerosis Risk in Communities (ARIC) study
por: Fletcher, Grace, et al.
Publicado: (2022)

Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database
por: Lutsey, Pamela L., et al.
Publicado: (2022)

Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study
por: Huxley, Rachel R., et al.
Publicado: (2013)

Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC‐NCS
por: Zhang, Michael J., et al.
Publicado: (2019)

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

Book Reviews: Hospitals and healing from antiquity to the later Middle Ages
por: MacLehose, William
Publicado: (2010)

No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend
por: Chamberlain, Alanna M., et al.
Publicado: (2016)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
por: Hernandez, Inmaculada, et al.
Publicado: (2019)

Book Reviews: Rooted in the earth, rooted in the sky: Hildegard of Bingen and premodern medicine
por: MacLehose, William F
Publicado: (2009)

Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis
por: Gallagher, Celine, et al.
Publicado: (2020)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lo5l0n6dppfro9m49borddnsor